Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
07:00am, Tuesday, 04'th Nov 2025
Novavax has successfully achieved U.S. BLA approval and completed both EU and U.S. marketing authorization transfers for Nuvaxovid™ to Sanofi in line with its CLA and its corporate strategy, securin
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025
08:00am, Thursday, 30'th Oct 2025
GAITHERSBURG, Md. , Oct. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m.
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why
06:46pm, Tuesday, 28'th Oct 2025
In the latest trading session, Novavax (NVAX) closed at $8.52, marking a -2.07% move from the previous day.
Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note
06:45pm, Wednesday, 22'nd Oct 2025
Novavax (NVAX) closed the most recent trading day at $8.46, moving 1.51% from the previous trading session.
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy
07:00am, Wednesday, 22'nd Oct 2025
Agreements signed to transfer one U.S.-based facility and sell certain equipment netting $60 million in cash and resulting in future cash savings of $230 million Novavax headquarters to remain in Gait
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 21'st Oct 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
06:46pm, Thursday, 16'th Oct 2025
Novavax (NVAX) reached $8.48 at the closing of the latest trading day, reflecting a -4.83% change compared to its last close.
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
01:08pm, Tuesday, 14'th Oct 2025
Shah Capital is reportedly pressing Novavax Inc. (NASDAQ:NVAX) to consider a sale of the biotech firm, citing continued struggles in the rollout of its COVID-19 vaccine.
Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps
06:09am, Tuesday, 14'th Oct 2025
Shah Capital has urged Novavax's board to pursue a sale of the biotech, citing a third consecutive year of poor roll-out of its COVID-19 shot, the hedge fund said on Tuesday.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:01am, Wednesday, 08'th Oct 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
GAITHERSBURG, Md. , Oct. 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® to Sanofi, in the European
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
06:46pm, Monday, 06'th Oct 2025
Novavax (NVAX) closed the most recent trading day at $9.08, moving 4.02% from the previous trading session.
Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider
06:46pm, Tuesday, 30'th Sep 2025
The latest trading day saw Novavax (NVAX) settling at $8.67, representing a +1.17% change from its previous close.
Novavax Announces Progress on Sanofi Agreement
09:01am, Tuesday, 30'th Sep 2025
GAITHERSBURG, Md. , Sept. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced progress on its collaboration and license agreement (CLA) with Sanofi regarding Novavax's Matrix-M®
Here's Why Novavax (NVAX) is a Strong Momentum Stock
10:50am, Friday, 26'th Sep 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
